Loading...
Please wait, while we are loading the content...
Similar Documents
The impact of transmission control measures during the first 50 days of the COVID-19 epidemic in China
| Content Provider | medRxiv |
|---|---|
| Author | Tian, Huaiyu Liu, Yonghong Li, Yidan Wu, Chieh-hsi Chen, Bin Moritz, U. G. Kraemer Li, Bingying Cai, Jun Xu, Bo Yang, Qiqi Wang, Ben Yang, Peng Cui, Yujun Song, Yimeng Zheng, Pai Wang, Quanyi Ottar, N. Bjornstad Yang, Ruifu Bryan, T. Grenfell Oliver, G. Pybus Dye, Christopher |
| Abstract | Respiratory illness caused by a novel coronavirus (COVID-19) appeared in China during December 2019. Attempting to contain infection, China banned travel to and from Wuhan city on 23 January and implemented a national emergency response. Here we evaluate the spread and control of the epidemic based on a unique synthesis of data including case reports, human movement and public health interventions. The Wuhan shutdown slowed the dispersal of infection to other cities by an estimated 2.91 days (95%CI: 2.54-3.29), delaying epidemic growth elsewhere in China. Other cities that implemented control measures pre-emptively reported 33.3% (11.1-44.4%) fewer cases in the first week of their outbreaks (13.0; 7.1-18.8) compared with cities that started control later (20.6; 14.5-26.8). Among interventions investigated here, the most effective were suspending intra-city public transport, closing entertainment venues and banning public gatherings. The national emergency response delayed the growth and limited the size of the COVID-19 epidemic and, by 19 February (day 50), had averted hundreds of thousands of cases across China.One sentence summary Travel restrictions and the national emergency response delayed the growth and limited the size of the COVID-19 epidemic in China.### Competing Interest StatementThe authors have declared no competing interest.### Funding StatementFunding for this study was provided by the Beijing Natural Science Foundation (JQ18025); Beijing Advanced Innovation Program for Land Surface Science; National Natural Science Foundation of China (81673234); Young Elite Scientist Sponsorship Program by CAST (YESS)(2018QNRC001)### Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesPopulation sizes for each city were collected from the China City Statistical Yearbook ( |
| Related Links | https://www.medrxiv.org/content/10.1101/2020.01.30.20019844v4 |
| Page Count | 29 |
| DOI | 10.1101/2020.01.30.20019844 |
| Language | English |
| Publisher Date | 2020-03-10 |
| Access Restriction | Open |
| Subject Keyword | Infectious Diseases (except HIV/AIDS) |
| Content Type | Text |
| Resource Type | Article |
| Subject | Infectious Diseases |
